Chiba, Japan

Takashi Kotsuka

This inventor holds 2 USPTO granted patents. Top assignee: Novo Nordisk A/s. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Takashi Kotsuka

Introduction

Takashi Kotsuka is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of lipase enzymes. With a total of 2 patents to his name, Kotsuka's work has garnered attention in the scientific community.

Latest Patents

Kotsuka's latest patents include a thermostable lipase isolated from Pseudomonas solanacearum. This innovation focuses on the lipase itself, the microorganisms that produce it, and the method of producing this valuable enzyme. His research has the potential to impact various applications in biotechnology and industry.

Career Highlights

Currently, Takashi Kotsuka is employed at Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to further his research and development efforts in enzyme technology. Kotsuka's expertise in lipase enzymes positions him as a key player in the advancement of biotechnological solutions.

Collaborations

Throughout his career, Kotsuka has collaborated with esteemed colleagues such as Kazunori Sakimoto and Masahiro Suzuki. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

In summary, Takashi Kotsuka is a prominent inventor whose work in lipase enzymes has made a significant impact in biotechnology. His contributions, along with his collaborations, continue to drive advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…